These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33689524)

  • 1. Evaluating Bayesian adaptive randomization procedures with adaptive clip methods for multi-arm trials.
    May Lee K; Lee JJ
    Stat Methods Med Res; 2021 May; 30(5):1273-1287. PubMed ID: 33689524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simulation study of outcome adaptive randomization in multi-arm clinical trials.
    Wathen JK; Thall PF
    Clin Trials; 2017 Oct; 14(5):432-440. PubMed ID: 28982263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of methodological considerations regarding adaptive stopping, arm dropping, and randomization in clinical trials.
    Granholm A; Kaas-Hansen BS; Lange T; Schjørring OL; Andersen LW; Perner A; Jensen AKG; Møller MH
    J Clin Epidemiol; 2023 Jan; 153():45-54. PubMed ID: 36400262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bayesian response-adaptive trial in tuberculosis: The endTB trial.
    Cellamare M; Ventz S; Baudin E; Mitnick CD; Trippa L
    Clin Trials; 2017 Feb; 14(1):17-28. PubMed ID: 27559021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative models and randomization techniques for Bayesian response-adaptive randomization with binary outcomes.
    Proper J; Connett J; Murray T
    Clin Trials; 2021 Aug; 18(4):417-426. PubMed ID: 33926267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simulation study for evaluating the performance of response-adaptive randomization.
    Du Y; Wang X; Jack Lee J
    Contemp Clin Trials; 2015 Jan; 40():15-25. PubMed ID: 25460340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
    Yu Q; Zhu L; Zhu H
    Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of methods for control allocation in multiple arm studies using response adaptive randomization.
    Viele K; Broglio K; McGlothlin A; Saville BR
    Clin Trials; 2020 Feb; 17(1):52-60. PubMed ID: 31630567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hybrid Bayesian adaptive design for dose response trials.
    Chang M; Chow SC
    J Biopharm Stat; 2005; 15(4):677-91. PubMed ID: 16022172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials.
    Thall P; Fox P; Wathen J
    Ann Oncol; 2015 Aug; 26(8):1621-8. PubMed ID: 25979922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Bayesian response-adaptive covariate-balanced randomization design with application to a leukemia clinical trial.
    Yuan Y; Huang X; Liu S
    Stat Med; 2011 May; 30(11):1218-29. PubMed ID: 21432894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian response adaptive randomization design with a composite endpoint of mortality and morbidity.
    Xu Z; Ma T; Tang L; Talisa VB; Chang CH
    Stat Med; 2024 Mar; 43(6):1256-1270. PubMed ID: 38258898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing three regularization methods to avoid extreme allocation probability in response-adaptive randomization.
    Du Y; Cook JD; Lee JJ
    J Biopharm Stat; 2018; 28(2):309-319. PubMed ID: 28323532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resist the Temptation of Response-Adaptive Randomization.
    Proschan M; Evans S
    Clin Infect Dis; 2020 Dec; 71(11):3002-3004. PubMed ID: 32222766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trials.
    Lin J; Bunn V
    Contemp Clin Trials; 2017 Mar; 54():48-59. PubMed ID: 28089763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of clinical development pathways to advance tuberculosis regimen development.
    Chang V; Phillips PPJ; Imperial MZ; Nahid P; Savic RM
    BMC Infect Dis; 2022 Dec; 22(1):920. PubMed ID: 36494644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An efficient Bayesian platform trial design for borrowing adaptively from historical control data in lymphoma.
    Normington J; Zhu J; Mattiello F; Sarkar S; Carlin B
    Contemp Clin Trials; 2020 Feb; 89():105890. PubMed ID: 31740427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of adaptation algorithm, timing, and stopping boundaries on the performance of Bayesian response adaptive randomization in confirmative trials with a binary endpoint.
    Jiang Y; Zhao W; Durkalski-Mauldin V
    Contemp Clin Trials; 2017 Nov; 62():114-120. PubMed ID: 28866294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian dose selection design for a binary outcome using restricted response adaptive randomization.
    Meinzer C; Martin R; Suarez JI
    Trials; 2017 Sep; 18(1):420. PubMed ID: 28886745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian adaptive randomization design incorporating propensity score-matched historical controls.
    Sawamoto R; Oba K; Matsuyama Y
    Pharm Stat; 2022 Sep; 21(5):1074-1089. PubMed ID: 35278032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.